Status:
COMPLETED
Parental Project and Premature Ovarian Insufficiency
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Primary Ovarian Insufficiency
Infertility
Eligibility:
FEMALE
18+ years
Brief Summary
One of the main repercussions of POI is infertility. When the diagnosis of POI is announced, the question of fertility is addressed and the patient is often directed towards egg donation or adoption w...
Detailed Description
The investigators propose to study patients with POI who were hospitalized in the endocrinology and reproductive medicine department of the Pitié-Salpêtrière Hospital for the etiological assessment of...
Eligibility Criteria
Inclusion
- Patients at least 18 years old at the time of the survey
- Patients with a diagnosis of PIO according to the current definition: cycle disturbances of more than 4 months and FSH \> 25 on 2 measurements one month apart
- Patients having been hospitalized in day hospital (HDJ) in the endocrinology and reproductive medicine department of the Pitié-Salpêtrière hospital for the etiological assessment of ovarian insufficiency and its repercussions between December 31, 1982 and January 12, 2021
- Valid contact information available: address, cell phone, e-mail
- Patients who have been informed and do not object to participate in the study
Exclusion
- Turner syndrome
- POI secondary to oncology treatments (chemotherapy, pelvic radiotherapy)
- Opposition to participating in the study
Key Trial Info
Start Date :
June 20 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 20 2022
Estimated Enrollment :
324 Patients enrolled
Trial Details
Trial ID
NCT05310617
Start Date
June 20 2022
End Date
June 20 2022
Last Update
October 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service d'endocrinologie et médecine de la reproduction
Paris, France, 75013